Zoetis Valuation

ZOE Stock  EUR 164.56  3.70  2.20%   
At this time, the company appears to be overvalued. Zoetis Inc maintains a prevalent Real Value of €139.8 per share. The last-minute price of the company is €164.56. Our model calculates the value of Zoetis Inc from examining the company fundamentals such as Profit Margin of 0.26 %, current valuation of 71.14 B, and Return On Asset of 0.13 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
164.56
Please note that Zoetis' price fluctuation is very steady at this time. Calculation of the real value of Zoetis Inc is based on 3 months time horizon. Increasing Zoetis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Zoetis stock is determined by what a typical buyer is willing to pay for full or partial control of Zoetis Inc. Since Zoetis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zoetis Stock. However, Zoetis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  164.56 Real  139.8 Hype  164.56 Naive  165.22
The real value of Zoetis Stock, also known as its intrinsic value, is the underlying worth of Zoetis Inc Company, which is reflected in its stock price. It is based on Zoetis' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zoetis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
138.52
Downside
139.80
Real Value
181.02
Upside
Estimating the potential upside or downside of Zoetis Inc helps investors to forecast how Zoetis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zoetis more accurately as focusing exclusively on Zoetis' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
157.61167.70177.80
Details
Hype
Prediction
LowEstimatedHigh
163.28164.56165.84
Details
Naive
Forecast
LowNext ValueHigh
163.94165.22166.49
Details

Zoetis Total Value Analysis

Zoetis Inc is at this time estimated to have takeover price of 71.14 B with market capitalization of 72.73 B, debt of 6.55 B, and cash on hands of 1.8 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Zoetis fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
71.14 B
72.73 B
6.55 B
1.8 B

Zoetis Investor Information

About 94.0% of the company outstanding shares are owned by institutional investors. The company last dividend was issued on the 20th of April 2023. Based on the key indicators related to Zoetis' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Zoetis Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Zoetis Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Zoetis has an asset utilization ratio of 54.14 percent. This implies that the Company is making €0.54 for each dollar of assets. An increasing asset utilization means that Zoetis Inc is more efficient with each dollar of assets it utilizes for everyday operations.

Zoetis Ownership Allocation

Zoetis Inc retains a total of 463.39 Million outstanding shares. The majority of Zoetis outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zoetis Inc to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zoetis Inc. Please pay attention to any change in the institutional holdings of Zoetis Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.

Zoetis Profitability Analysis

The company reported the revenue of 8.08 B. Net Income was 2.11 B with profit before overhead, payroll, taxes, and interest of 5.63 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Zoetis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Zoetis and how it compares across the competition.

About Zoetis Valuation

The stock valuation mechanism determines Zoetis' current worth on a weekly basis. Our valuation model uses a comparative analysis of Zoetis. We calculate exposure to Zoetis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zoetis's related companies.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. ZOETIS INC operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10000 people.

8 Steps to conduct Zoetis' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Zoetis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Zoetis' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Zoetis' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Zoetis' revenue streams: Identify Zoetis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Zoetis' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Zoetis' growth potential: Evaluate Zoetis' management, business model, and growth potential.
  • Determine Zoetis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Zoetis' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Zoetis Stock analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets